Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Capítulo de Livro
|
000 b . c .–PresentKaufman, LloydSell Your Own Damn Movie, 2011, p.23-32RoutledgeTexto completo disponível |
|
2 |
Material Type: Artigo
|
000101 PACLITAXEL/CARBOPLATIN (TC) VS. PACLITAXEL/CARBOPLATIN FOLLOWED BY TOPOTECAN (TOP) IN FIRST-LINE TREATMENT OF OVARIAN CANCER FIGO STAGES IIB-IV. MATURE RESULTS OF AN INTERGROUP PHASE III TRIALLück, H J ; Weber, B ; Quaas, J ; Lortholary, A ; SchadeBrittinger, C ; Richter, B ; Bourgeois, H ; Kuhn, W ; Meyer, F ; Pfisterer, JInternational journal of gynecological cancer, 2005-09, Vol.15 (Suppl 2), p.79-79 [Periódico revisado por pares]Oxford: BMJ Publishing Group LTDTexto completo disponível |
|
3 |
Material Type: Artigo
|
000102 PROGRESS IN THE UK FAMILIAL OVARIAN CANCER SCREENING STUDY (UKFOCSS)Jacobs, I J ; Mackay, J ; Rosenthal, A N ; Fraser, L ; Perault, L ; Mozersky, J ; Skates, S J ; Menon, UInternational journal of gynecological cancer, 2005-09, Vol.15 (Suppl 2), p.80-80 [Periódico revisado por pares]Oxford: BMJ Publishing Group LTDTexto completo disponível |
|
4 |
Material Type: Artigo
|
000103 PACLITAXEL-CARBOPLATIN-GEMCITABINE VS. PACLITAXEL-CARBOPLATIN AS FIRSTLINE TREATMENT OF OVARIAN CANCER: A RANDOMIZED PHASE III GCIG INTERGROUP STUDY (AGO-OVAR 9, GINECO-TCG, NSGO-OC-0102)A du Bois ; Schroeder, W ; Jelic, S ; Weber, B ; Sehouli, J ; Keern, J ; Priou, F ; Huober, J ; Railing, M ; Ray-Coquard, I ; Heilmann, V ; Surges, A ; Pfisterer, J ; Gropp, M ; Staehle, A ; Wimberger, P ; Jackisch, C ; Mueller, H HInternational journal of gynecological cancer, 2005-09, Vol.15 (Suppl 2), p.80-80 [Periódico revisado por pares]Oxford: BMJ Publishing Group LTDTexto completo disponível |
|
5 |
Material Type: Artigo
|
000104 POTENTIAL INFLUENCE OF FAMILY HISTORY AND ENVIRONMENTAL FACTORS ON THE PENETRANCE OF BRCA1/BRCA2 MUTATIONSBeller, UInternational journal of gynecological cancer, 2005-09, Vol.15 (Suppl 2), p.80-80 [Periódico revisado por pares]Oxford: BMJ Publishing Group LTDTexto completo disponível |
|
6 |
Material Type: Artigo
|
00010 ANTIANGIOGENESIS - A NEW TREATMENT MODALITY FOR OVARIAN CANCER PATIENTSSchröder, W ; Abadie, S ; Witteveen, P O ; Campone, M ; Viens, P ; Jalava, T ; Masson, E ; Bilic, S ; Chlistalla, A ; A du BoisInternational journal of gynecological cancer, 2005-09, Vol.15 (Suppl 2), p.53-54 [Periódico revisado por pares]Oxford: BMJ Publishing Group LTDTexto completo disponível |
|
7 |
Material Type: Artigo
|
00011 PHASE II STUDY OF FIRST-LINE CARBOPLATIN FOLLOWED SEQUENTIALLY BY GEMCITABINE AND PACLITAXEL IN ADVANCED OVARIAN CANCER: AN AUSTRALIAN AND NEW ZEALAND GYNAECOLOGICAL ONCOLOGY GROUP STUDYFriedlander, M ; Harnett, P ; Findlay, M ; Wyld, D ; Buck, MInternational journal of gynecological cancer, 2005-09, Vol.15 (Suppl 2), p.54-54 [Periódico revisado por pares]Oxford: BMJ Publishing Group LTDTexto completo disponível |
|
8 |
Material Type: Artigo
|
00012 CYTOREDUCTIVE SURGERY PLUS INTRAPERITONEAL HYPERTHERMIC PERFUSION IN THE TREATMENT OF RECURRENT EPITHELIAL OVARIAN CANCERMueller, H ; Hahn, MInternational journal of gynecological cancer, 2005-09, Vol.15 (Suppl 2), p.54-54 [Periódico revisado por pares]Oxford: BMJ Publishing Group LTDTexto completo disponível |
|
9 |
Material Type: Artigo
|
00013 PRIMARY SURGERY OR NEOADJUVANT CHEMOTHERAPY IN THE TREATMENT OF ADVANCED STAGE EPITHELIAL OVARIAN CANCERGungor, M ; Ortac, F ; Sonmezer, MInternational journal of gynecological cancer, 2005-09, Vol.15 (Suppl 2), p.54-55 [Periódico revisado por pares]Oxford: BMJ Publishing Group LTDTexto completo disponível |
|
10 |
Material Type: Artigo
|
00014 A PHASE II STUDY OF THE AGO OVARIAN CANCER STUDY GROUP (AGO-OVAR 2.6): ZD1839 IN COMBINATION WITH TAMOXIFEN IN REFRACTORY OVARIAN CANCERSehouli, J ; Wagner, U ; A du Bois ; Pfisterer, J ; Houber, J ; Loibl, S ; Lueck, H J ; Gropp, M ; Staehle, A ; Schmalfeldt, B ; Meier, W ; Jackisch, CInternational journal of gynecological cancer, 2005-09, Vol.15 (Suppl 2), p.55-55 [Periódico revisado por pares]Oxford: BMJ Publishing Group LTDTexto completo disponível |